Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INROADS: ADS-5102 in MS Walking Impairment
NCT03436199Phase 3Completed
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of amantadine in multiple sclerosis (MS). Started Mar 2018; status: completed.
02
Drugs
amantadine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03436199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436199.